Quotient Clinical

Mark Egerton, CEO, Quotient Clinical, discusses reformulation drug development services for a changing market more

9 May 2016 10:40 Opinion

Quotient Clinical has acquired formulation development specialist Co-Formulate Limited more

24 Dec 2015 11:50 News

Healthcare investor GHO Capital has acquired Quotient Clinical, a Translational Pharmaceutics company more

2 Dec 2015 15:44 News

​Sygnature Discovery has successfully delivered a drug candidate to Corcept Therapeutics. more

30 Jul 2015 09:32 News

Quotient Clinical's chief scientific officer Dr Peter Scholes has been awarded an honorary professorship in the School of Pharmacy at the University of Nottingham. more

29 Jul 2015 12:27 News

Quotient Clinical has doubled capacity through the acquisition of a second GMP manufacturing facility and the construction of new formulation development and pharmaceutical analysis laboratories. more

14 Jul 2015 11:50 News

Quotient Clinical has commenced its 50th RapidFACT (Rapid Formulation development And Clinical Testing) programme — a significant milestone in the development of this service. more

7 Feb 2014 14:21 Technology

Quotient Clinical has entered a collaboration with Pulmatrix Inc., a biotech company based in Massachusetts, US, to support the development of PUR0200, a new bronchodilator therapy for the treatment of chronic obstructive pulmonary disease and the... more

14 Aug 2013 12:10 Technology

Quotient Clinical, part of Quotient Bioresearch (Quotient), has announced that three new pharmaceutical and biotech clients have selected its RapidFACT service to support the development of optimal drug products for pulmonary, transdermal... more

22 Mar 2013 13:57 Technology